Guadalupe Hayes-Mota is an award-winning healthcare leader transforming organizations across the private, public, and nonprofit sectors. Guadalupe is currently the Director of Global Supply Chain and Manufacturing at Ultragenyx Pharmaceutical, where he leads the manufacturing and distribution (department) of the company’s medicines to 35 countries. Previously, he directed the manufacturing and distribution of 13 medications to 93 countries at several biotechs (Biogen, Amgen & GSK), supplying millions of patients with medicine. Before entering biotech, Guadalupe ran the largest free healthcare system in the nation (UCLA Health) that provided over 30,000 underserved patients with care every year. While at RAND Corporation, he worked with the US government to help develop and implement the Affordable Care Act during the Obama Administration that gave access to 20M with health insurance.
In 2021, Governor Charlie Baker appointed Guadalupe to the newly formed Massachusetts Rare Disease Advisory Council to advise the Governor, Senate, House of Representative, & Department of Public Health on rare disease policy in Massachusetts. He also serves on the Board of Directors Save One Life and the MIT LBGTQ+ Alumni Association, which he refounded and led as President.
Guadalupe has been recognized by Business Insider as one of six powerful LGBTQ+ executives to have on corporate boards; by PharmaVoice, who named him as one of the 100 Most Inspiring People in the Life Science Industry; and was named to the Boston Business Journal 40 under 40.